Dexcom Inc
NASDAQ:DXCM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dexcom Inc
NASDAQ:DXCM
|
US |
|
DCB Bank Ltd
NSE:DCBBANK
|
IN |
|
K
|
Kingspan Group PLC
ISEQ:KRX
|
IE |
|
Nick Scali Ltd
ASX:NCK
|
AU |
|
MS Industrie AG
XETRA:MSAG
|
DE |
|
Select Medical Holdings Corp
NYSE:SEM
|
US |
|
Reach PLC
LSE:RCH
|
UK |
|
T
|
Troax Group AB (publ)
F:5TOA
|
SE |
|
O
|
Oil and Gas Development Co Ltd
LSE:37OC
|
PK |
|
T
|
Tencent Music Entertainment Group
HKEX:1698
|
CN |
|
F
|
F5 Inc
SWB:FFV
|
US |
|
MedPlus Health Services Ltd
NSE:MEDPLUS
|
IN |
|
D
|
Deutsche Post AG
XMUN:DHL
|
DE |
|
V
|
Visa Inc
XHAM:3V64
|
US |
|
Indo Tambangraya Megah Tbk PT
OTC:ITAYY
|
ID |
Wall St Price Targets
DXCM Price Targets Summary
Dexcom Inc
According to Wall Street analysts, the average 1-year price target for DXCM is 86.52 USD with a low forecast of 67.67 USD and a high forecast of 117.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DXCM's stock price target?
Price Target
86.52
USD
According to Wall Street analysts, the average 1-year price target for DXCM is 86.52 USD with a low forecast of 67.67 USD and a high forecast of 117.6 USD.
What is the Revenue forecast for Dexcom Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 5 years is 12%.
What is the Operating Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Operating Income over the next 5 years is 19%.
What is the Net Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Net Income over the next 5 years is 19%.
